Literature DB >> 16044701

An up-to-date on clinical management of human cystic echinococcosis.

A Teggi1.   

Abstract

More than one thousand of patients with more than two thousand of Echinococcus granulosus hydatid cysts were observed during the last 20 years. The therapeutic approach ranged from chemotherapy with benzimidazole carbamates (mebendazole and albendazole) to surgery, percutaneous non conventional treatment, and a "wait and see" approach, on the basis of the clinical picture, of the compliance and of the socio-economic background of each patient. The observed results, mainly those regarding chemotherapy, were briefly summarized and discussed. Most important point to underline is the need of data about a more prolonged follow-up on wider casuistries of patients both treated (with chemotherapy, with surgery, with percutaneous non conventional treatment) and not treated, to obtain a more suitable evaluation of the long-term outcome of the performed clinical approach. Moreover, a multidisciplinary approach is advisable to assure a better clinical management to patients with cystic echinococcosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16044701

Source DB:  PubMed          Journal:  Parassitologia        ISSN: 0048-2951


  4 in total

1.  Human cystic echinococcosis: old problems and new perspectives.

Authors:  Alessandra Siracusano; Antonella Teggi; Elena Ortona
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-11-01

2.  Right-Sided Cardiac Hydatid Cyst Complicated With Pulmonary Embolization: A Pediatric Case Report.

Authors:  Maryem Assamti; Hammam Rasras; Nabila Ismaili; Noha Elouafi
Journal:  Cureus       Date:  2020-11-16

3.  Tibial hydatidosis: a case report.

Authors:  Berhe Gebreseslassie Kassa; Melisachew Mulatu Yeshi; Amanuel Haile Abraha; Tewelde Tesfaye Gebremariam
Journal:  BMC Res Notes       Date:  2014-09-11

4.  Authors' Response.

Authors:  Moncef Belhassen-García; Montserrat Alonso-Sardón; Antonio Muro; Juan Luis Muñoz Bellido; Javier Pardo-Lledias
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.